Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL8614699 | 0.98 | MAPT (0.39) | MAPTSLC22A16CES2CES1CYP1A2 | |
| Hydrochloric Acid SCHEMBL316715 | 0.98 | MAPT (0.43) | MAPTSLC22A16CES2CES1CYP1A2 | |
| Iodide SCHEMBL1157375 | 0.98 | MAPT (0.39) | MAPTSLC22A16CES2CES1CYP1A2 | |
| Fluoride Ion SCHEMBL15993970 | 0.98 | MAPT (0.39) | MAPTSLC22A16CES2CES1CYP1A2 | |
| Water SCHEMBL15994022 | 0.98 | MAPT (0.39) | MAPTSLC22A16CES2CES1CYP1A2 | |
| Hydrochloric Acid SCHEMBL19025641 | 0.98 | MAPT (0.39) | MAPTSLC22A16CES2CES1CYP1A2 | |
| Glycerin SCHEMBL3308566 | 0.89 | SLC22A16 (0.41) | MAPTSLC22A16CYP1A2MEN1LMNA | |
| SCHEMBL5582502 | 0.88 | MAPT (0.44) | MAPTSLC22A16CYP1A2TSHRCHRM2 | |
| SCHEMBL9631685 | 0.85 | CES2 (0.48) | MAPTCES2CYP1A2TSHRMEN1 | |
| SCHEMBL200766 | 0.84 | CES2 (0.52) | MAPTCES2CYP1A2TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 808 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559735-B2 | Device for detecting organophosphates | PLANTVAX, INC. (US) | 2026-02-24 | — | — | US | claimed |
| US-12257566-B2 | Carbon dioxide absorbent including phenolate-based ionic liquid and aliphatic alcohol and method of separating carbon dioxide using the same | SK INNOVATION CO., LTD. (KR) | 2025-03-25 | — | — | US | claimed |
| US-12239616-B2 | Food supplement and composition comprising choline butyrate salt and/or butyrylcholine | ABERGAVENNY NV (BE) | 2025-03-04 | — | — | US | claimed |
| US-20250001390-A1 | Carbon Dioxide Absorbent Including Phenolate-Based Ionic Liquid and Aliphatic Alcohol and Method of Separating Carbon Dioxide Using the Same | SK INNOVATION CO., LTD. (KR) | 2025-01-02 | — | — | US | claimed |
| CN-119215983-A | Quaternary ammonium salt ionic liquid catalyst for synthesizing diether fluorene and preparation method thereof | 濮阳市盛通聚源新材料有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-117305432-B | SNP (Single nucleotide polymorphism) marker related to Chinese maleylcholine esterase activity as well as detection primer and application thereof | 中国农业科学院北京畜牧兽医研究所 | 2024-09-06 | — | — | CN | claimed |
| CN-117305432-A | SNP (Single nucleotide polymorphism) marker related to Chinese maleylcholine esterase activity as well as detection primer and application thereof | 中国农业科学院北京畜牧兽医研究所 | 2023-12-29 | — | — | CN | claimed |
| CN-113528119-B | Conjugated polymer nanoparticle composite fluorescent probe and preparation method and application thereof | 齐鲁工业大学 | 2023-10-31 | — | — | CN | claimed |
| CN-113975224-B | Ionic liquid-reversed micelle drug-loaded delivery system for epidermis desensitization treatment, and preparation method and application thereof | 中国药科大学 | 2023-10-24 | — | — | CN | claimed |
| US-20230218551-A1 | FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE | ABERGAVENNY NV (BE) | 2023-07-13 | — | — | US | claimed |
| WO-2001085985-A1 | ASSAY FOR DETECTING, MEASURING AND MONITORING THE ACTIVITIES AND CONCENTRATIONS OF PROTEINS AND METHODS OF USE THEREOF | UNITED STATES ARMY MEDICAL RESEARCH AND MATERIAL COMMAND (US) | 2001-11-15 | — | — | WO | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0674232-B1 | Recording sheets | XEROX CORP (US) | 2000-05-31 | — | — | EP | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1997021737-A1 | PHOTOINITIATOR COMPOSITION CONTAINING A BORATE SALT AND A HYPERVALENT ATOM-CONTAINING SALT | SPECTRA GROUP LIMITED, INC. (US) | 1997-06-19 | — | — | WO | claimed |
| EP-0315782-B1 | Method for the production of proteins | THOMAE GMBH DR K (DE) | 1994-09-28 | — | — | EP | claimed |
| EP-0591472-A1 | EXPRESSION OF ENZYMATICALLY ACTIVE RECOMBINANT HUMAN ACETYLCHOLINESTERASE AND USES THEREOF | BIO-TECHNOLOGY GENERAL CORPORATION (US) | 1994-04-13 | — | — | EP | claimed |
| WO-1993001830-A1 | EXPRESSION OF ENZYMATICALLY ACTIVE RECOMBINANT HUMAN ACETYLCHOLINESTERASE AND USES THEREOF | BIO-TECHNOLOGY GENERAL CORP. (US) | 1993-02-04 | — | — | WO | claimed |
| EP-0464388-A1 | Detection assays having chromogenic and nonchromogenic, hypocromogenic, bathochromogenic or hypsochromogenic substrates | TECHNICON INSTRUMENTS CORPORATION (a New York corporation) (US) | 1992-01-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559735-B2 | Device for detecting organophosphates | BCHE, LIPE, ACHE | MAPT 3814/4885SLC22A16 4025/4885CES2 4/4885 |
| US-20230218551-A1 | FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE | SLC10A2, CHAT, BCHE | MAPT 942/4885SLC22A16 1070/4885CES2 1345/4885 |
| US-12239616-B2 | Food supplement and composition comprising choline butyrate salt and/or butyrylcholine | SLC10A2, CHAT, BCHE | MAPT 942/4885SLC22A16 1070/4885CES2 1345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.